Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study) by Yu Qiang Soh, Zheng Xian Thng, Wei Kiong Ngo, Colin S Tan, Tock Han Lim, Louis W Lim, Augustinus Laude, Darren Choy, Wen Jun Song, Helen Fang Mi, Koh Lilian, Jacob Yu Hang Chin, Karen Jhi Wen Chia, Issac Too, Nicola Y Gan, Rajesh Rajagopalan

Get full text